Benjamin Ambrosy

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Induced Apoptosis

Respiratory Syndrome Coronavirus

Atomic Force Microscopy

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Stephan Ludwig, Benjamin Ambrosy, Oliver Planz, Sebastian Schloer, Ursula Rescher, Stephan Ludwig
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs. Pharmaceutics 14 (9) (2022)